Log in to save to my catalogue

Updating and Refining of Economic Evaluation of Rotavirus Vaccination in Spain: A Cost–Utility and B...

Updating and Refining of Economic Evaluation of Rotavirus Vaccination in Spain: A Cost–Utility and B...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e9b283782ac74d55aa4bb24ecae5fd38

Updating and Refining of Economic Evaluation of Rotavirus Vaccination in Spain: A Cost–Utility and Budget Impact Analysis

About this item

Full title

Updating and Refining of Economic Evaluation of Rotavirus Vaccination in Spain: A Cost–Utility and Budget Impact Analysis

Publisher

Switzerland: MDPI AG

Journal title

Viruses, 2024-07, Vol.16 (8), p.1194

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Two vaccines against rotavirus diseases, Rotarix® and RotaTeq®, are being marketed in Spain; but rotavirus is not presently among the diseases covered by universal vaccination in Spain. The aim of this study was to assess the efficiency of extending Spain’s current targeted rotavirus vaccination strategy including only preterm babies, to a policy o...

Alternative Titles

Full title

Updating and Refining of Economic Evaluation of Rotavirus Vaccination in Spain: A Cost–Utility and Budget Impact Analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e9b283782ac74d55aa4bb24ecae5fd38

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e9b283782ac74d55aa4bb24ecae5fd38

Other Identifiers

ISSN

1999-4915

E-ISSN

1999-4915

DOI

10.3390/v16081194

How to access this item